Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19434115 | 0.69 | CA1 (0.46) | CA1CA2CA4 | |
| SCHEMBL2434740 | 0.68 | — | — | |
| SCHEMBL5547886 | 0.67 | CA1 (0.50) | CA1CA2CA4 | |
| SCHEMBL20412506 | 0.66 | NOS1 (0.33) | CA1CA2CA4 | |
| SCHEMBL7989298 | 0.64 | — | — | |
| SCHEMBL9637783 | 0.63 | CA1 (0.45) | CA1CA2CA4 | |
| SCHEMBL24064957 | 0.63 | ALDH1A1 (0.32) | — | |
| SCHEMBL17063633 | 0.62 | CA1 (0.59) | CA1CA2CA4 | |
| SCHEMBL11904003 | 0.61 | CA1 (0.46) | CA1CA2CA4 | |
| SCHEMBL24798983 | 0.60 | CA1 (0.33) | CA1CA2CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230172961-A1 | THERAPEUTICS FOR COVID-19 | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2023-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230172961-A1 | THERAPEUTICS FOR COVID-19 | ACE, ACE2, PNP | CA1 4885/4885CA2 4566/4885CA4 3280/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.